Development and preliminary results of the Financial Incentive Coercion Assessment questionnaire

Journal of Substance Abuse Treatment

Volumn 43, Issue 1, 2012, Pages 86-93

  Byrne, Margaret M ^a   Croft, Jason R ^b   French, Michael T ^c   Dugosh, Karen L ^b   Festinger, David S ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b TREATMENT RESEARCH INSTITUTE   (United States)

^c University of Miami   (United States)

Author keywords

Financial incentives; Perceived coercion; Substance abuse research

Indexed keywords

ADULT; ARTICLE; CLINICAL RESEARCH; FEMALE; FINANCIAL INCENTIVE COERCION ASSESSMENT; FOLLOW UP; HUMAN; INFORMED CONSENT; MALE; METHODOLOGY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH SUBJECT;

ADULT; COERCION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PATIENT PARTICIPATION; PATIENT SELECTION; PILOT PROJECTS; QUESTIONNAIRES; RESEARCH; RESEARCH DESIGN; SUBSTANCE-RELATED DISORDERS;

EID: 84861878541     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.10.002     Document Type: Article

References (35)

1. Ackerman T.F. The ethical framework for the practice of paying research subjects. IRB 1989, 11:1-4.
2. Bains N., Pickett W., Hoey J. The use and impact of incentives in population-based smoking cessation programs: A review. American Journal of Health Promotion 1998, 12:307-320.
3. Brody B.A. The ethics of biomedical research: An international perspective 1998, Oxford Press, Cambridge, MA.
4. Cahill K., Perera L., Perera R. Competitions and incentives for smoking cessation. Cochrane Database of Systematic Reviews 2011, 13:CD004307.
5. Caldwell P.H., Hamilton S., Tan A., Craig J.C. Strategies for increasing recruitment to randomised controlled trials: Systematic review. PLOS Medicine 2010, 7:e1000368.
6. Croft J.R., Festinger D.S., Dugosh K.L., Marlowe D.B., Rosenwasser B.J. Does size matter? Salience of follow-up payments in drug abuse research. IRB 2007, 19:15-19.
7. Doody M.M., Sigurdson A.S., Kampa D., Chimes K., Alexander B.H., Ron E., Linet M.S. Randomized trial of financial incentives and delivery methods for improving response to a mailed questionnaire. American Journal of Epidemiology 2003, 157:643-651.
8. Festinger D.S., Marlowe D.B., Croft J.R., Dugosh K.L., Mastro N.K., Lee P.A., Dematteo D.S., Patapis N.S. Do research payments precipitate drug use of coerce participation?. Drug and Alcohol Dependence 2005, 78:275-281.
9. Festinger D.S., Marlowe D.B., Dugosh K.L., Croft J.R., Arabia P.L. Higher magnitude cash payment improve research follow-up rates without increasing drug use or perceived coercion. Drug and Alcohol Dependence 2008, 96:128-135.
10. García-Fernández G., Secades-Villa R., García-Rodríguez O., Alvarez-López H., Fernández-Hermida J.R., Fernández-Artamendi S., Higgins S.T. Long-term benefits of adding incentives to the community reinforcement approach for cocaine dependence. European Addiction Research 2011, 17:139-145.
11. Gardner W., Hoge S.K., Bennet N., Roth L.H., Lidz C.W., Monahan J., Mulvey E.P. Two scales for measuring patients' perceptions of coercion during mental hospital admissions. Behavioral Science and the Law 1993, 11:307-321.
12. Halpern S.D., Karlawish J.H., Casarett D., Berlin J.A., Asch D.A. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Archives of Internal Medicine 2004, 164:801-803.
13. Johnson M.O., Remien R.H. Adherence to research protocols in a clinical context: Challenges and recommendations from behavioral intervention trials. American Journal of Psychotherapy 2003, 57:348-360.
14. Kamb M.L., Rhodes F., Hoxworth T., Rogers J., Lentz A., Kent C., MacGowen R., Petersen T.A. What about money? Effect of small monetary incentives on enrolment, retention and motivation to change behavior in an HIV/STD prevention counseling intervention. Sexually Transmitted Infection 1998, 74:253-255.
15. Lind S.E. Financial issues and incentives related to clinical research and innovative therapies. The ethics of research involving human subjects: Facing the 21st century 1996, 185-202. University Publishing Group, Frederick, MD. H.Y. Vanderpool (Ed.).
16. LoRusso P.M., Anderson A.B., Boerner S.A., Averbuch S.D. Making the investigational oncology pipeline more efficient and effective: Are we headed in the right direction?. Clinical Cancer Research 2010, 16:5956-5962.
17. Macklin R. The paradoxical case of payment as benefit to research subjects. IRB 1989, 11:1-3.
18. OHRP Protecting human research subjects: Institutional review board guidebook 1993, National Institutes of Health, Washington DC.
19. Neuer A. Treating study volunteers as customers. CenterWatch 2003, 10:4-7.
20. Palmer W.E. Monetary inducements to research participation. Pharo 1985, 26-30.
21. Robiner W.N. Enhancing adherence in clinical research. Contemporary Clinical Trials 2005, 26:59-77.
22. Roozen H.G., Boulogne J.J., van Tulder M.W., van den Brink W., De Jong C.A., Kerkhof A.J. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine, and opioid addition. Drug and Alcohol Dependence 2004, 9:1-13.
23. Singer E., Bossarte R.M. Incentives for survey participation when they "coercive"?. American Journal of Preventive Medicine 2006, 31:411-418.
24. Smith H.L. Ethical considerations in research involving human subjects. Ethics in Science and Medicine 1979, 6:167-175.
25. Thompson D., Baranowski T., Cullen K., Watson K., Canada A., Bhatt R., Zakeri I. Food, fun and fitness Internet program for girls: Influencing log-on rate. Health Education Research 2007, 23:228-237.
26. Touloumi G., Pocock S.J., Babiker A.G., Darbyshire J.H. Impact of missing data due to selective dropouts in cohort studies and clinical trials. Epidemiology 2002, 13:347-355.
27. Urquhart J. Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens. Pharmacoeconomics 1999, 15:217-228.
28. Volpp K.G., Gurmankin Levy A., Asch D.A., Berlin J.A., Murphy J.J., Gomez A., Lerman C. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiological Biomarkers and Prevention 2006, 15:12-18.
29. Volpp K.G., Troxel A.B., Pauly M.V., Glick H.A., Puig A., Asch D.A., Audrian-McGovern J. A randomized, controlled trial of financial incentives for smoking cessation. New England Journal of Medicine 2009, 360:699-709.
30. Walker J., Fairley C.K., Urban E., Chen M.Y., Bradshaw C., Walker S.M., Hocking J.S. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Austrailia. BMC Public Health 2011, 11:156.
31. Wall J.W., Ni Mhurchu C., Blakely T., Rodgers A., Wilton J. Effectiveness of monetary incentives in modifying dietary behavior: A review of randomized, controlled trails. Nutrition Reviews 2006, 64:518-531.
32. Watson J.M., Torgerson D.J. Increasing recruitment to randomised trails: A review of randomised controlled trials. BMC Research Methodology 2006, 19:34.
33. Wertheimer A., Miller F.G. Payment for research participation: A coercive offer?. Journal of Medical Ethics 2008, 34:389-392.
34. Wertheimer A. Coercion 1987, Princeton University Press, Princeton, New Jersey.
35. Wilkinson M. Payments to research subjects. Monash Bioeth Review 2005, 24:70-74.